Primary Clinical Response of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma (r/r FL) in China

被引：0
|
作者：
Song, Yuqin [1 ]
Ying, Zhitao [1 ]
Yang, Haiyan [2 ]
Guo, Ye [3 ]
Li, Wenyu [4 ]
Zou, Dehui [5 ,6 ,7 ]
Wu, Jianqiu [8 ]
Yang, Su [9 ]
Zhang, Pian [9 ]
Ma, Meilin [9 ]
Zhou, Zisong [9 ]
Zheng, Hongxia [9 ]
Zhu, Jun [1 ]
机构：
[1] Peking Univ Canc Hosp & Inst, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China
[2] Chinese Acad Sci, Inst Canc & Basic Med IBMC, Dept Med Oncol, Hangzhou, Peoples R China
[3] Shanghai Dongfang Hosp, Tongji Univ, Dept Med Oncol, Shanghai, Peoples R China
[4] Guangdong Acad Sci, Dept Lymphoma, Guangdong Provincial Peoples Hosp, Guangzhou, Guangdong, Peoples R China
[5] Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Blood Dis Hosp, Tianjin, Peoples R China
[6] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China
[7] Peking Union Med Coll, Tianjin, Peoples R China
[8] Affiliated Hosp Nanjing Med Univ, Jiangsu Inst Canc Res, Jiangsu Canc Hosp, Dept Med Oncol,Jiangsu Red Cross Canc Ctr, Nanjing, Peoples R China
[9] JW Therapeut Shanghai Co Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-150085
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2434
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Efficacy and Safety of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma in China
    Song, Yuqin
    Ying, Zhitao
    Yang, Haiyan
    Guo, Ye
    Li, Wenyu
    Zou, Dehui
    Wu, Jianqiu
    Tian, Alex
    Huang, Tony
    Zhou, Zisong
    Ma, Meilin
    Yang, Su
    Qin, Yun
    Zhu, Jun
    BLOOD, 2022, 140 : 10329 - 10331
  • [2] Preliminary Safety and Efficacy of Relmacabtagene Autoleucel (relma-cel) in Adults with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL) in China
    Ying, Zhitao
    Zhou, Keshu
    Li, Lanfang
    Li, Wenyu
    Yang, Su
    Liu, Yun
    Gu, Yongen
    Zhou, Zisong
    Tian, Alex
    Song, Yuqin
    Zhu, Jun
    BLOOD, 2022, 140 : 7470 - 7471
  • [3] Preliminary efficacy and safety of Relmacabtagene autoleucel (Carteyva) in adults with relapsed/refractory follicular lymphoma in China: A phase I/II clinical trial
    Ying, Zhitao
    Zou, Dehui
    Yang, Haiyan
    Wu, Jianqiu
    Guo, Ye
    Li, Wenyu
    Liu, Hui
    Wang, Chris
    Ma, Laura
    Yang, Su
    Zhou, Zisong
    Qin, Yun
    Song, Yuqin
    Zhu, Jun
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : E436 - E438
  • [4] Understanding the patient experience in follicular lymphoma (FL), relapsed/refractory FL (R/R FL), and relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
    Bell, Jill A.
    Cherepanov, Dasha
    Revicki, Dennis
    Speck, Rebecca M.
    Swett, Laura
    Stumpo, Kate
    Rong, Yuanxin
    Gordon, Leo I.
    QUALITY OF LIFE RESEARCH, 2019, 28 : S67 - S68
  • [5] Clinical Response of CD19 CAR-T Cells (relmacabtagene autoleucel, relma-cel) in Adults with Heavily-Pre-Treated Relapsed/Refractory (r/r) Large B-Cell Lymphoma in China
    Zhu, Jun
    Ying, Zhitao
    Song, Yuqin
    Yang, Haiyan
    Guo, Ye
    Li, Wenyu
    Zou, Dehui
    Zhou, Daobin
    Wang, Zhao
    Zhang, Mingzhi
    Wu, Jianqiu
    Liu, Hui
    Zhang, Pian
    Yang, Su
    Zhou, Zisong
    Zheng, Hongxia
    BLOOD, 2020, 136
  • [6] HUMANISTIC BURDEN IN RELAPSED OR REFRACTORY (R/ R) FOLLICULAR LYMPHOMA (FL): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Forbes, C.
    Pustulka, I
    Nunez-Gonzalez, S.
    Kumar, J.
    VALUE IN HEALTH, 2023, 26 (12) : S451 - S452
  • [7] Real-world early outcomes of axicabtagene ciloleucel for relapsed or refractory (R/R) follicular lymphoma (FL).
    Jacobson, Caron Alyce
    Hemmer, Michael T.
    Hu, Zhen-Huan
    Frank, Matthew Joshua
    Popplewell, Leslie
    Ahmed, Nausheen
    Lin, Yi
    Best, Timothy
    Beygi, Sara
    Miao, Harry H.
    Fu, Christine
    Sun, Fang
    Xu, Hairong
    Pasquini, Marcelo C.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Safety and Efficacy of Relmacabtagene Autoleucel (relma-cel) in Adults with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL): Updated Results from a Phase II Open-Label Study in China
    Song, Yuqin
    Zhou, Keshu
    Li, Lanfang
    Liang, Aibin
    Qin, Yun
    Xia, Zhen
    Gu, Yongen
    Zhou, Zisong
    Tian, Alex
    Zhu, Jun
    BLOOD, 2023, 142
  • [9] Efficacy Outcomes of Treatments for Double Relapsed/Refractory Follicular Lymphoma (R/R FL): A Systematic Literature Review
    Kahl, Brad S.
    Patel, Anik R.
    Zaidi, Omer
    Snedecor, Sonya J.
    Purdum, Anna G.
    BLOOD, 2020, 136
  • [10] Cost-Effectiveness Analysis of Relmacabtagene Autoleucel for Relapsed or Refractory Large B-Cell Lymphoma in China
    Lin, Ziyi
    Zuo, Chenyu
    Jiang, Yifan
    Su, Wen
    Yao, Xing
    Man, Yu
    Wu, Qiong
    Xuan, Jianwei
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 37 : 41 - 48
12345